Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Targeting mitochondrial α" (30 stories)

Top Headline Story

Targeting mitochondrial α-ketoglutarate sequestration disables dual oncogenic drivers and metabolic adaptability in pancreatic ductal adenocarcinoma
Lead StoryNaturegeneral
Jun 25

Targeting mitochondrial α-ketoglutarate sequestration disables dual oncogenic drivers and metabolic adaptability in pancreatic ductal adenocarcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE84S1FGak9FWkdfcU1MVVoxMHJEeW9RMnlWaHBCNV9BSUUyY2Jpa3lYWlh0V01SQUF1WHJ2Qk1Gd25KM3ZhdGFEdGI1NmhBU1FtX3loMFdNTEFPcWV0ZHlF?oc=5" target="_blank">Targeting mitochondrial α-ketoglutarate sequestration disables dual oncogenic drivers and metabolic adaptability in pancreatic ductal adenocarcinoma</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
200+13m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

100+13m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

500+23m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

10000+23m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Search Results for "Targeting mitochondrial α"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Targeting mitochondria for the treatment of neurodegenerative diseases
Frontiersgeneral

Targeting mitochondria for the treatment of neurodegenerative diseases

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPcmFkR3RZUEhyN3hNYTJBWDRSXzlEYnpJTi1ud3lVekxQUXdZSnU3b2QyZFI3UnRVV05TT2F1dGxza0NQQ3hzWGYxcDZGWjM2WEZmYVRCS0IxNURWTGF2R21TY29PTm1IYUFvNWx1c0pCb0F1b0M3NWpyZUl1N3U5SjBjQTN4VHdKLXlMM1d6Q1ZZLUVU?oc=5" target="_blank">Targeting mitochondria for the treatment of neurodegenerative diseases</a>  <font color="#6f6f6f">Frontiers</font>

New compound targets mitochondrial damage in Parkinson’s models
Parkinson's News Todayworld

New compound targets mitochondrial damage in Parkinson’s models

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNVDJ0TGlTazdQV2c0V0FEanhJT0NPcE1zaHlHTEhuYWlEZE8ta0p0TzV4UlpsRnVPckVJRWwyV2pPaWdwM3pnYXJYaG1JT2w2YXpkNHVkTVhELV9NbTVyalZBbXEwamdaOTdHR3VqMGVDNHJBZkFaaDh3TVBwVm1NUmVfWlMwc2RGdXZFSFRYbl84eG44?oc=5" target="_blank">New compound targets mitochondrial damage in Parkinson’s models</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy
Naturegeneral

Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1JTmRvelV1aURTTEFkdlQxc2tJVFVFdXJVOHc1eGx6WHVaNXpCc3hFMzFxeXMxbm9GblRaTXg5TURTTVMzV1BlQ1BoZVRnVzZOaHdhb2E0WU44Nkk1ODNj?oc=5" target="_blank">Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy</a>  <font color="#6f6f6f">Nature</font>

Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases
Frontiersworld

Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPVS1GVlNSTHFYeXNyaHZuTVdFUE40UnJvSlNJMHlzVy1ZOThMT0JpQjZsdVN1MC1LclZZaEg5Z3pIVVlUV1ByUElXVl9YMmpRWnNvV080VUlhbHZZckhwdHB6QnoxUl9NdTRmTERjaWM0VUxZb3AxSWhEQjlGT3JOMFVzMDRxem9XU05BdzlRQVY3X2Rl?oc=5" target="_blank">Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases</a>  <font color="#6f6f6f">Frontiers</font>

Modified Alpha-Synuclein Impairs Mitochondrial Transport, New Study Finds
Neurology Todaytech

Modified Alpha-Synuclein Impairs Mitochondrial Transport, New Study Finds

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBDdW9IMW1rakdmU1lPbnZyRXcyYWxwajZEd3VGbmpibEtRS003WkE3eU9FNDZRWmtDZDFaZ3Zib1Z4Vk1fLVdRN1RBRE1NRFY5eXVFd0pMVFd6UnVmbEhoTmJWM0J0Z3hwNDhCZWVXQUc3S0FhTC0w?oc=5" target="_blank">Modified Alpha-Synuclein Impairs Mitochondrial Transport, New Study Finds</a>  <font color="#6f6f6f">Neurology Today</font>

N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis
Naturegeneral

N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNUk5oaV9sekFaeGNUbllnU2ZFWGl4SE1QSHJwV0JoVnpjX1QweTdWUnoyLTVXc0RYckxpZlRXWlR6UDJfRV9HZUdOTUtNVW9vdThGUWZwVnNjbXV0dmZJ?oc=5" target="_blank">N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis</a>  <font color="#6f6f6f">Nature</font>

The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis
Frontiersgeneral

The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOc0lEVHJ4bXMwOFZFM2h6RHlWQ0o2MjNreXA0bzRxaTQ4Z2NYZkxUS2NUcDRlVzBvN3JhdGNXblE2UUxua3hiZldSeEVzakp3NU1GVWkyOUNFSTRmeWhKVmxKMm8yMUNEdmllR1RUSkhrUjlVUGU4SmotNnh1SjVWSmZDZkc1VVE1aGwtVVVFMWU2bzV0?oc=5" target="_blank">The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis</a>  <font color="#6f6f6f">Frontiers</font>

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam
Natureworld

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHd25wcUlIbU9qc2ZTR2RrNkNiUlJUbWNhQmM4Y2puTDF3cWd0T1EtYjlGVElvejhxellSdDM4eWxuTGt1MFh3QmdhM01CXzVRc1JkSzFsLUhhTHV1V1Y4?oc=5" target="_blank">Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam</a>  <font color="#6f6f6f">Nature</font>

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Frontierstech

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQcTRicjNOSzctamozY1A5VGdCTW5VVGc5dlJBSG8tOXBDTkwzdU85eVRWZ1oyTnQ0TnhNTHZEZk1hRl9qUGMzQUsxbm5ORm9Oa3ZNYTRHM0w2MXpZMjJBNDNwQm82MEFQZ3drUnFFdk15UTRZdFFHSHpuaVdLdTlsWF81bFdCWGdxLUlRMFN6VzkwTEhuWFFwN0FBSGdlclQwaWMxZGZXemt3M2M?oc=5" target="_blank">Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities</a>  <font color="#6f6f6f">Frontiers</font>

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models
Naturegeneral

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1XQlZyUU9ocGVEbzJfY09FWWo1R2w2M25zVHB2R2EtOE0tYkxMajhiNVpRb1E0ci1xYUhCX1p3ZmJMeUxPY0h6Slh0aHVRQmJOODd1bWVNZTktQnR3Q1hV?oc=5" target="_blank">Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
Frontiersgeneral

Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZUNLZkVjUHFpT0NPS1FMMkJwV0pBYU0yUVoyamZmUXpRX21zYXFiTnM1NGFFbkN4VXlFNVNQdnlheXAyUy1BYklfdEw0YV9qVl9oYmNYS2lPOVNVMFFJeGlEOE12dGZwMHJsSnNZQ2lEZ1VpbVNTQzYtazZ4ZWh6Zm8zc3NJRmpTMEhF?oc=5" target="_blank">Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy</a>  <font color="#6f6f6f">Frontiers</font>

Annonaceous acetogenins mimic AA005 targets mitochondrial trifunctional enzyme alpha subunit to treat obesity in male mice
Natureworld

Annonaceous acetogenins mimic AA005 targets mitochondrial trifunctional enzyme alpha subunit to treat obesity in male mice

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9tUzJtWV80eGNIQVlNazVTMlJsVzQzb0ExM0JMOG9LMmtlVXZKSG5YMjdUX2l2RGxqd21kUUNZM0V5VEg1STdaM0hyTThFaDNITkk1NWxoNTVURjlCTk5J?oc=5" target="_blank">Annonaceous acetogenins mimic AA005 targets mitochondrial trifunctional enzyme alpha subunit to treat obesity in male mice</a>  <font color="#6f6f6f">Nature</font>

The relationship of alpha-synuclein to mitochondrial dynamics and quality control
Frontiersgeneral

The relationship of alpha-synuclein to mitochondrial dynamics and quality control

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNazRQMkRpUkItMnhvaW9VaGVreU83LWY5SFl3Y29VZWxvMUhSRG93M2Zld3JPdllFUHFEWnYzRXpCWVJFdkt5SmQ4Y2RZN1gyWTBXemFQVENZei1uN3pGeHliOElsY3N5SEdBNVRBOXJmMXpWZmF6NjVHVHJmamlqMzFyNDZvTWZZNUMxZlI4WEFZVlUyeHNpT09wVU1jSjRC?oc=5" target="_blank">The relationship of alpha-synuclein to mitochondrial dynamics and quality control</a>  <font color="#6f6f6f">Frontiers</font>

Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity | npj Parkinson's Disease
Naturegeneral

Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity | npj Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xR3pFTUV6U0t4NzlpSmNqb0pBZnMyRE40RjdnRU1ONUNZdENBU2ZTakJ5b19vSmh6Mi1nNE9qNDRnRnpGUkFVRUttRWFVUi1qWGNfTjJTdmNVZFEwME9z?oc=5" target="_blank">Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity | npj Parkinson's Disease</a>  <font color="#6f6f6f">Nature</font>

Targeting mitochondrial dysfunction with traditional Chinese medicine for inflammatory bowel disease: a comprehensive review
Frontiersworld

Targeting mitochondrial dysfunction with traditional Chinese medicine for inflammatory bowel disease: a comprehensive review

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPYlhtVFlLRmU5OXVwdjFvR1p1Z2dzUXJsd3dOMXcxbUxoVEd0Mng3bmVGM0JRVFBQcllmUVUzYVlQajhEUHBBWm1mUS1sa2kwQml2VERwamhjQi1veG9HMEdnc3A3TzhWd19JRGdVTVdZZnVGSy1MdlB1S1VfMHRhVm4xTVlvQ3ZHaDlrZkVlWGxIVjRZ?oc=5" target="_blank">Targeting mitochondrial dysfunction with traditional Chinese medicine for inflammatory bowel disease: a comprehensive review</a>  <font color="#6f6f6f">Frontiers</font>

Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia
Natureworld

Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE0wSFV3TkhWTFpDVzNsS2JXUFZBZzJSZ05tdDBxNUVpSFc4X3oxUXc4dXp4Y0l5VE5KOWdGc1FmYXB6b0VoT2hMVlZLSzRTaXlEbGtB?oc=5" target="_blank">Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
Frontiersworld

Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPVVd2eUprOXF5SHVLMks4YkFhckt1ekRONzNmLXBGVlhGNlVmd0ItRHZvVlFnbVNybElCdDhfQVFPQ3BDRDVMMTN6UHFXREpKRjZoNWNKaWlFNjhsTFU4aFpEbVJ6VzJqWF9BWEpuX3ZMUGsyQklNejZxdXVZRmh6dy1ScXVyb0FqU1hCREUxaWIwdw?oc=5" target="_blank">Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies</a>  <font color="#6f6f6f">Frontiers</font>

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
Naturegeneral

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ZVS14UFN0cVR1UlRmcjYyS2lnUXNmMmYzQk1DSHZJTTl0Slh5cU54bjUwX3g1RHQ3U1VBTGFqdE5PWUZZUE4wSTItTmdneWpNTkdZT1k0NlcwZUktcHBB?oc=5" target="_blank">Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities
Natureworld

Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xQVNqQzBEUGdoUkN6ampselppdlgtOUNKUExEX1ltRktsLTJKR0w5RU1SSy1yZnRrX05RdEdOYnRTRExvWUtrTjExTlB2NjBhM1JLYzVZWWM0LUtVMW9N?oc=5" target="_blank">Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson’s disease through inhibition of H3K4me3 demethylation
Natureworld

Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson’s disease through inhibition of H3K4me3 demethylation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE56dXJPdjJyT1ZSdHJsSHY4WG5WbVBJTHlyZXFsckxVUWhaMzNsWXFGMlloLW9RYnVwcUducWJrcVY3QUZIMU51MTBXVVhtZzZ0NW96UDZtWElySGt6blBR?oc=5" target="_blank">Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson’s disease through inhibition of H3K4me3 demethylation</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Frontiersworld

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPNEVHa08xeGVLWXlKb0ZUc0h5R1UzRzhkRV9jSHhqU2dCMktNQXYyWlZUZldGVFhhR2h4elpaSVNfS1d2NWctVi1vWDhXNDd3a09RbXhRV0JLejBja3ZVcXJHOGVtXzkwbWFNa1I3ZWY4YnBtcW9CVGhxLVRyeG03Y0wyOG9Ielo1b1JYRUw1VDhkdjZGTkZlQXhpNA?oc=5" target="_blank">Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy</a>  <font color="#6f6f6f">Frontiers</font>

The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Natureworld

The crosstalk between HIFs and mitochondrial dysfunctions in cancer development

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIMWVNMHRReU9RVlBvbUE1Nkt0V1R6cDJDel9rLTR3RUJYdjJFUkdpUGkzZVhxMjhEUF9mazRrMlNFaFRXQ3g1d19wN1g5TEl3Mk80Z3FldGtIdWNXZGYw?oc=5" target="_blank">The crosstalk between HIFs and mitochondrial dysfunctions in cancer development</a>  <font color="#6f6f6f">Nature</font>

Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer
Naturegeneral

Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4yeS1nMVl4R0ctbTVoc252S2x6c2gwbG0yRHNlRDd1bk44aG1wb2dKQmgwSUdOcEpnX0NKZ2hDNldzaDVqb1RRakZpejQ2UjFQMFFGdEdsR2cwVnlSeGJV?oc=5" target="_blank">Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges
Frontiersworld

Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOdXlSNFZWejQxakprelJuYUgxVnBheXk0WjdxRHdjam1BckxHTjhrc1NnU1VSNDVKdDhwaDhTNkl5ZW1mZE95RDhVOGFmSWRhM0szOXYxbnlHck92blNtSk9IMTNKOWxCRlctTlU3dDNlSk1mNGloam41VU9nbEtFMG14MkttTldpSXhpdTA2RE9kZw?oc=5" target="_blank">Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges</a>  <font color="#6f6f6f">Frontiers</font>

Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
Naturegeneral

Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0c3R3SXdNN1FFaUJCTUhXZWJaRkt3dXM3el9rRGxVOFg0dXJVcE9LelpIc001d3I3YW5rTGRHX2dWd0pEVm5uajFiUm9VVnRJNkM0Yy1DNkpsY3BPZ3Fj?oc=5" target="_blank">Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20</a>  <font color="#6f6f6f">Nature</font>

A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein
Naturegeneral

A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9WRDM3M2VmOTFnT0RFR0FhWXNRV216R2JzdE9hUlNOY3RseTJhQUJ5WEl1NWdiMFQxNFFOLUVOc1lYZWFnbGRnQlRnMVRJcnRpVTNIc29POWpvOEd1U1E?oc=5" target="_blank">A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein</a>  <font color="#6f6f6f">Nature</font>

Design of diverse, functional mitochondrial targeting sequences across eukaryotic organisms using variational autoencoder
Natureworld

Design of diverse, functional mitochondrial targeting sequences across eukaryotic organisms using variational autoencoder

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5zWjlGcmtNY25EdW5TQmU4b3phb0pvTklza3gxYWZwYnhFMW55Rk96c1B0ODZsZzFsQUUwNXRkdDRNNnYyRXIxUENzdTVwdWRiOGV2NTFKa2xkMUlsekln?oc=5" target="_blank">Design of diverse, functional mitochondrial targeting sequences across eukaryotic organisms using variational autoencoder</a>  <font color="#6f6f6f">Nature</font>

Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells
Naturegeneral

Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1qM04zT1lXcS1RVTF2Y3hCVDBER3lnQWNIUXNUclZzNmlpZk9kTGx2Mkd6c3h6U2cxVkJHR0tFNlE2S2RPenk2VjJrdFV6NE5XR2x3alJSRFZBcjExb0M4?oc=5" target="_blank">Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells</a>  <font color="#6f6f6f">Nature</font>

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
Frontiersgeneral

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOLTczb0hjTHRSUTVjRFVGTFJ5Um5VYXRudndmOWZfV2U4R0wyWk12Nnp6clNwVnFnaVZqZE9TSjNfUlZaVVFQOGIwYmgxcWIwcVcwd0R0cU5LQ0t2U3B1OU5UaFltYjF0d3lDWGF1Z2szaFQ2NU1PTnN5YnVwc3BJVkc5SjE2SnB1ODg2aVN2X3hyUQ?oc=5" target="_blank">Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update</a>  <font color="#6f6f6f">Frontiers</font>

"Targeting mitochondrial α" — Live Google News Trends & Headlines